Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Release kinetics of copeptin in patients undergoing transcoronary ablation of septal hypertrophy.

Liebetrau C, Nef H, Szardien S, Dörr O, Willmer M, Voss S, Troidl C, Hoffmann J, Rixe J, Rolf A, Hamm C, Möllmann H.

Clin Chem. 2013 Mar;59(3):566-9. doi: 10.1373/clinchem.2012.194001. Epub 2013 Jan 3.

2.

Release kinetics of cardiac biomarkers in patients undergoing transcoronary ablation of septal hypertrophy.

Liebetrau C, Möllmann H, Nef H, Szardien S, Rixe J, Troidl C, Willmer M, Hoffmann J, Weber M, Rolf A, Hamm C.

Clin Chem. 2012 Jun;58(6):1049-54. doi: 10.1373/clinchem.2011.178129. Epub 2012 Apr 13.

3.

Reference Values and Release Kinetics of B-Type Natriuretic Peptide Signal Peptide in Patients with Acute Myocardial Infarction.

Liebetrau C, Gaede L, Dörr O, Blumenstein J, Rosenburg S, Hoffmann J, Troidl C, Hamm CW, Nef HM, Möllmann H, Richards AM, Pemberton CJ.

Clin Chem. 2015 Dec;61(12):1532-9. doi: 10.1373/clinchem.2015.244327. Epub 2015 Oct 27.

4.

Release kinetics of early ischaemic biomarkers in a clinical model of acute myocardial infarction.

Liebetrau C, Nef HM, Dörr O, Gaede L, Hoffmann J, Hahnel A, Rolf A, Troidl C, Lackner KJ, Keller T, Hamm CW, Möllmann H.

Heart. 2014 Apr;100(8):652-7. doi: 10.1136/heartjnl-2013-305253. Epub 2014 Jan 31.

PMID:
24488609
5.

Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy.

Liebetrau C, Möllmann H, Dörr O, Szardien S, Troidl C, Willmer M, Voss S, Gaede L, Rixe J, Rolf A, Hamm C, Nef H.

J Am Coll Cardiol. 2013 Sep 10;62(11):992-8. doi: 10.1016/j.jacc.2013.05.025. Epub 2013 Jun 7.

6.

Release kinetics of inflammatory biomarkers in a clinical model of acute myocardial infarction.

Liebetrau C, Hoffmann J, Dörr O, Gaede L, Blumenstein J, Biermann H, Pyttel L, Thiele P, Troidl C, Berkowitsch A, Rolf A, Voss S, Hamm CW, Nef H, Möllmann H.

Circ Res. 2015 Feb 27;116(5):867-75. doi: 10.1161/CIRCRESAHA.116.304653. Epub 2014 Dec 16.

7.

Release kinetics of N-terminal pro-B-type natriuretic peptide in a clinical model of acute myocardial infarction.

Liebetrau C, Gaede L, Dörr O, Troidl C, Voss S, Hoffmann J, Paszko A, Weber M, Rolf A, Hamm C, Nef H, Möllmann H.

Clin Chim Acta. 2014 Feb 15;429:34-7. doi: 10.1016/j.cca.2013.11.017. Epub 2013 Dec 1.

PMID:
24291058
8.

Incremental value of copeptin for rapid rule out of acute myocardial infarction.

Reichlin T, Hochholzer W, Stelzig C, Laule K, Freidank H, Morgenthaler NG, Bergmann A, Potocki M, Noveanu M, Breidthardt T, Christ A, Boldanova T, Merki R, Schaub N, Bingisser R, Christ M, Mueller C.

J Am Coll Cardiol. 2009 Jun 30;54(1):60-8. doi: 10.1016/j.jacc.2009.01.076.

9.

Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction).

Maisel A, Mueller C, Neath SX, Christenson RH, Morgenthaler NG, McCord J, Nowak RM, Vilke G, Daniels LB, Hollander JE, Apple FS, Cannon C, Nagurney JT, Schreiber D, deFilippi C, Hogan C, Diercks DB, Stein JC, Headden G, Limkakeng AT Jr, Anand I, Wu AH, Papassotiriou J, Hartmann O, Ebmeyer S, Clopton P, Jaffe AS, Peacock WF.

J Am Coll Cardiol. 2013 Jul 9;62(2):150-60. doi: 10.1016/j.jacc.2013.04.011. Epub 2013 Apr 30.

10.

Endogenous stress response in Tako-Tsubo cardiomyopathy and acute myocardial infarction.

Meissner J, Nef H, Darga J, Kovacs M, Weber M, Hamm C, Möllmann H, Twerenbold R, Reiter M, Heinisch C, Stelzig C, Reichlin T, Mueller C.

Eur J Clin Invest. 2011 Sep;41(9):964-70. doi: 10.1111/j.1365-2362.2011.02487.x. Epub 2011 Mar 9.

PMID:
21391994
11.

Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction.

Potocki M, Reichlin T, Thalmann S, Zellweger C, Twerenbold R, Reiter M, Steuer S, Bassetti S, Drexler B, Stelzig C, Freese M, Winkler K, Haaf P, Balmelli C, Hochholzer W, Osswald S, Mueller C.

Heart. 2012 Apr;98(7):558-65. doi: 10.1136/heartjnl-2011-301269. Epub 2012 Feb 15.

PMID:
22337952
12.

Temporal release pattern of copeptin and troponin T in patients with suspected acute coronary syndrome and spontaneous acute myocardial infarction.

Slagman A, Searle J, Müller C, Möckel M.

Clin Chem. 2015 Oct;61(10):1273-82. doi: 10.1373/clinchem.2015.240580. Epub 2015 Sep 4.

13.

Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction.

Gu YL, Voors AA, Zijlstra F, Hillege HL, Struck J, Masson S, Vago T, Anker SD, van den Heuvel AF, van Veldhuisen DJ, de Smet BJ.

Clin Res Cardiol. 2011 Dec;100(12):1069-76. doi: 10.1007/s00392-011-0343-y. Epub 2011 Jul 16.

14.

Release kinetics of high-sensitivity cardiac troponins I and T and troponin T upstream open reading frame peptide (TnTuORF) in clinically induced acute myocardial infarction.

Liebetrau C, Gaede L, Wolter JS, Homann J, Meyer A, Dörr O, Nef HM, Troidl C, Hamm CW, Möllmann H, Richards AM, Pemberton CJ.

Biomarkers. 2017 May - Jun;22(3-4):304-310. doi: 10.1080/1354750X.2016.1252965. Epub 2016 Nov 22.

PMID:
27775442
15.

Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy.

Lawrenz T, Lieder F, Bartelsmeier M, Leuner C, Borchert B, Meyer zu Vilsendorf D, Strunk-Mueller C, Reinhardt J, Feuchtl A, Stellbrink C, Kuhn H.

J Am Coll Cardiol. 2007 Jun 19;49(24):2356-63. Epub 2007 Jun 4.

16.

Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience.

Kuhn H, Lawrenz T, Lieder F, Leuner C, Strunk-Mueller C, Obergassel L, Bartelsmeier M, Stellbrink C.

Clin Res Cardiol. 2008 Apr;97(4):234-43. Epub 2007 Dec 10.

PMID:
18071624
17.

Combined testing of high-sensitivity troponin T and copeptin on presentation at prespecified cutoffs improves rapid rule-out of non-ST-segment elevation myocardial infarction.

Giannitsis E, Kehayova T, Vafaie M, Katus HA.

Clin Chem. 2011 Oct;57(10):1452-5. doi: 10.1373/clinchem.2010.161265. Epub 2011 Aug 1.

18.

Copeptin and high sensitive troponin for a rapid rule out of acute myocardial infarction?

Giavarina D, Carta M, Fortunato A, Wratten ML, Hartmann O, Soffiati G.

Clin Lab. 2011;57(9-10):725-30.

PMID:
22029188
19.

[Transcoronary ablation of septal hypertrophy versus dual-chamber cardiac pacing for the treatment of aged patients with hypertrophic obstructive cardiomyopathy].

Gao YC, Li Y, Han ZH, Zhang XL, Zhao H, Jiang TY.

Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Apr;35(4):333-6. Chinese.

PMID:
17711659
20.

Association of copeptin with myocardial infarct size and myocardial function after ST segment elevation myocardial infarction.

Reinstadler SJ, Klug G, Feistritzer HJ, Mayr A, Harrasser B, Mair J, Bader K, Streil K, Hammerer-Lercher A, Esterhammer R, Metzler B.

Heart. 2013 Oct;99(20):1525-9. doi: 10.1136/heartjnl-2013-303975. Epub 2013 May 22.

PMID:
23697651

Supplemental Content

Support Center